BROOKE BERING: Open Payments
NPI 1346555315 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 78 payments from 17 companies in 2025. Trend: 2023 $1,357 · 2024 $1,704 · 2025 $1,607
Food & beverage: $1,527Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $260 |
| Janssen Biotech, Inc. | 5 | $187 |
| Novartis Pharmaceuticals Corporation | 9 | $183 |
| GENZYME CORPORATION | 8 | $140 |
| UCB, Inc. | 5 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Lilly USA, LLC | 4 | $89 |
| Biofrontera Inc. | 4 | $86 |
| Galderma Laboratories, L.P. | 4 | $76 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $73 |
Products named: DUPIXENT, TREMFYA, COSENTYX, Bimzelx, SKYRIZI, RINVOQ, NEMLUVIO, ILUMYA.
Industry payments across MD — which companies pay providers there.
